Dr. Gomperts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit Street Wac 729
Boston, MA 02114Phone+1 617-726-1728- Is this information wrong?
Summary
- Dr. Stephen Gomperts is a neurologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from University of California San Francisco School of Medicine and has been in practice 16 years. He specializes in Movement Disorders and Dementia & is the founding Director of the MGH Lewy Body Dementia Unit.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2001 - 2002
University of California San Francisco School of MedicineClass of 2001
Certifications & Licensure
NH State Medical License 2021 - 2025
RI State Medical License 2021 - 2024
ME State Medical License 2021 - 2024
MA State Medical License 2005 - 2024- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Lewy body dementia: Overcoming barriers and identifying solutions.Kanishka Agarwal, Wendi Backler, Ece Bayram, Leah Bloom, Bradley F Boeve, Jang-Ho Cha, Maria Denslow, Tanis J Ferman, Douglas Galasko, James E Galvin, Stephen N Gomper...> ;Alzheimer's & Dementia. 2024 Mar 1
- Clearing the Smoke: What Protects Smokers from Parkinson's Disease?Kenneth N Rose, Michael A Schwarzschild, Stephen N Gomperts> ;Movement Disorders. 2024 Feb 1
- Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer's disease model.Qiuchen Zhao, Megi Maci, Morgan R Miller, Heng Zhou, Fang Zhang, Moustafa Algamal, Yee Fun Lee, Steven S Hou, Stephen J Perle, Hoang Le, Alyssa N Russ, Eng H Lo, Dmitr...> ;Molecular Neurodegeneration. 2023 Dec 1
- Join now to see all
Press Mentions
- EIP Pharma Announces Presentation of Positive Clinical Trial Results with Neflamapimod at the 13th Clinical Trials in Alzheimer's Disease (CTAD) MeetingNovember 7th, 2020
EIP Pharma Announces Positive Phase 2 Results for Neflamapimod in Mild-to-Moderate Dementia with Lewy Bodies (DLB)October 6th, 2020
Letter to the Editor: O’Brien Exemplifies Caring and CompassionJuly 17th, 2019- Join now to see all
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
